Trial intelligence / Profile preview

Liposomal Bupivacaine for Postoperative Pain in Lung Transplant Patients

NCT07641647Phase 4Not yet recruiting

Sponsor
Second Affiliated Hospital of Zhejiang University School of Medicine
Start
Jul 2026
Primary completion
Jul 2028
Countries
1
01

Overview

A Phase 4 trial of liposomal bupivacaine in postoperative pain, sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Planned start Jul 2026; status: not yet recruiting.

02

Drugs

liposomal bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT07641647.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07641647.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call